A comparison of immunotherapy delivery methods for allergen immunotherapy

Immunological effects and tolerability of a new fast updosed immunologically enhanced subcutaneous immunotherapy formulation with optimized allergen/adjuvant ratio

(2012) O. Pfaar et al.   ALLERGY

An alternative allergen:adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment of grass-pollen allergy

(2012) C. Rask et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections

(2012) Gabriela Senti et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: Looking at the published evidence

(2012) Moisés A. Calderón et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trial

(2012) Stephen R. Durham et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Perspectives on allergen-specific immunotherapy in childhood: An EAACI position statement

(2012) M. A. Calderon et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY

Mechanisms of allergen-specific immunotherapy

(2012) Hiroyuki Fujita et al.   Clinical and Translational Allergy

Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?

(2011) G. Senti et al.   ALLERGY

Immunotherapy concepts under investigation

(2011) T. M. Kündig   ALLERGY

Immunological mechanisms of sublingual allergen-specific immunotherapy

(2011) N. Novak et al.   ALLERGY

A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy*

(2011) O. Pfaar et al.   ALLERGY

European Academy of Allergy and Clinical Immunology task force report on ‘dose-response relationship in allergen-specific immunotherapy’

(2011) M. A. Calderón et al.   ALLERGY

Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen

(2011) Lawrence M. DuBuske et al.   ALLERGY AND ASTHMA PROCEEDINGS

Immunotherapy for allergic rhinitis

(2011) S. M. Walker et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study

(2011) L. Klimek et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Design and Recruitment for the GAP Trial, Investigating the Preventive Effect on Asthma Development of an SQ-Standardized Grass Allergy Immunotherapy Tablet in Children with Grass Pollen–Induced Allergic Rhinoconjunctivitis

(2011) Erkka Valovirta et al.   CLINICAL THERAPEUTICS

CpG DNA as a vaccine adjuvant

(2011) Christian Bode et al.   Expert Review of Vaccines

Novel Administration Routes for Allergen-Specific Immunotherapy: A Review of Intralymphatic and Epicutaneous Allergen-Specific Immunotherapy

(2011) Seraina von Moos et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: A comparison based on meta-analyses

(2011) Paolo Maria Matricardi et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies

(2011) Louisa K. James et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Epicutaneous allergen-specific immunotherapy ameliorates grass pollen–induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study

(2011) Gabriela Senti et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

GA2LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma

(2010) T. Zuberbier et al.   ALLERGY

Immunotherapy with depigmented-polymerized mixed tree pollen extract: a clinical trial and responder analysis

(2010) O. Pfaar et al.   ALLERGY

Efficacy and Safety of a Glutaraldehyde-Modified House Dust Mite Extract in Allergic Rhinitis

(2010) Herbert Riechelmann et al.   American Journal of Rhinology & Allergy

Epicutaneous/transcutaneous allergen-specific immunotherapy: rationale and clinical trials

(2010) Gabriela Senti et al.   Current Opinion in Allergy and Clinical Immunology

Designing CD8+ T cell vaccines: it's not rocket science (yet)

(2010) Jonathan W Yewdell   CURRENT OPINION IN IMMUNOLOGY

Sublingual Allergen-Specific Immunotherapy Adjuvanted with Monophosphoryl Lipid A: A Phase I/IIa Study

(2010) Oliver Pfaar et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: A randomized controlled trial

(2010) Stefan Zielen et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study

(2009) H. Ott et al.   ALLERGY

Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial

(2009) G. Senti et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy

(2009) Gabriela Senti et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber

(2009) Friedrich Horak et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Viral Sequestration of Antigen Subverts Cross Presentation to CD8+ T Cells

(2009) Eric F. Tewalt et al.   PLoS Pathogens

Use of topical steroids is largely restricted by irrational emotional concerns in both patients and physicians

(2008) T. Zuberbier et al.   ALLERGY

The coming of age of virus-like particle vaccines

(2008) Gary T. Jennings et al.   BIOLOGICAL CHEMISTRY

The European Union CREATE Project: A model for international standardization of allergy diagnostics and vaccines

(2008) Martin D. Chapman et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial

(2008) G. Senti et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells

(2007) Jean-Pierre Allam et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood

(2007) Bengt Björkstén et al.   PEDIATRIC ALLERGY AND IMMUNOLOGY